Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population
Medical Science Monitor · 2012 · 18 (8) · CR512-CR517
DOI: 10.12659/msm.883272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2012. Verfasst von Helena Buzková und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, 1st Faculty of Medicine, Charles University and General Teaching Hospital, Prague, Czech Republic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, 1st Faculty of Medicine, Charles University and General Teaching Hospital, Prague, Czech Republic.
Zitieren
APA
Buzková, H., Pechandová, K., Danzig, V., Vareka, T., Perlik, F., Zak, A., & Slanar, O. (2012). Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population. Medical Science Monitor, 18(8), CR512-CR517. https://doi.org/10.12659/msm.883272
Vancouver
Buzková H, Pechandová K, Danzig V, Vareka T, Perlik F, Zak A, et al. Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population. Medical Science Monitor. 2012;18(8):CR512-CR517. doi:10.12659/msm.883272
BibTeX
@article{Buzkov2012,
author = {Buzková, Helena and Pechandová, Kristina and Danzig, Vilém and Vareka, Tomá and Perlik, Frantisek and Zak, Ales and Slanar, Ondrej},
title = {Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population},
journal = {Medical Science Monitor},
year = {2012},
volume = {18},
number = {8},
pages = {CR512--CR517},
doi = {10.12659/msm.883272}
}
EUVIMED